Media Thread, page-31

The stuff in this interview is pretty good

A lot.of people seemed to shrug off the FDA deal .

LC seems pretty stoked , and makes some very strong points

1. They are testing on live patients ...and although they are officially.testing for toxicity ....she expects that effectiveness may well be observed in patients .

2. She also says that about 1 in 10000 applicants achieve what lMU just have with the FDA ( she may have been exaggerating)

I'd say that the market response to Mondays announcement might be on a delayed fuse .

Plus ....they are gunna be able to take a snap shot of the Hervax Data ....

So it's possible that cats might be out of the bag in coming months .

The market will get it when it gets it .

The opportunity to keep accumulating at these levels is unlikely to be there for too much longer l reckon